急性胰腺炎中生理盐水与林格液及危重症死亡率:全国住院患者数据库研究
该回顾性队列研究利用日本诊断程序组合数据库(2010年7月至2021年3月),纳入ICU或HDU收治、存活至少3天并在入院3天内接受充分液体复苏的成人急性胰腺炎患者,按主要液体类型分为生理盐水组(>80%生理盐水)和林格液组(>80%林格液),采用倾向性评分匹配比较院内死亡率。共纳入8710例,生理盐水组657例(7.5%),林格液组8053例(92.5%),匹配后各578对。生理盐水组院内死亡率显著高于林格液组(12.8% [474/578] vs 8.5% [49/578];风险差4.3%;95%CI 0.3%至8.3%)。作者认为,对于ICU或HDU收治并接受充分液体复苏的急性胰腺炎患者,林格液可能优于生理盐水作为首选输注治疗。
要点
- 匹配后生理盐水组院内死亡率12.8%(474/578)vs 林格液组8.5%(49/578),风险差4.3%(95%CI 0.3%至8.3%)。
- 研究纳入ICU或HDU收治、存活≥3天且入院3天内接受充分液体复苏(≥[10 ml/kg/hr*1 h + 1 ml/kg/hr*71 h] ml)的成人急性胰腺炎患者。
- 分组依据为主要液体类型:生理盐水组>80%生理盐水,林格液组>80%林格液。
- 全部8710例中,657例(7.5%)以生理盐水为主,8053例(92.5%)以林格液为主;倾向性评分匹配后各578例。
- 作者认为,对于ICU或HDU收治并接受充分液体复苏的急性胰腺炎患者,林格液可能优于生理盐水作为首选输注治疗。
适用人群与场景
- 日本诊断程序组合数据库中2010年7月至2021年3月住院的成人急性胰腺炎患者。
- 纳入标准:入住ICU或HDU、存活至少3天、入院3天内接受充分液体复苏(≥[10 ml/kg/hr*1 h + 1 ml/kg/hr*71 h] ml,包括急诊室输注)。
- 分组:生理盐水组>80%生理盐水,林格液组>80%林格液。
诊断标准与关键阈值
- 充分液体复苏定义:入院3天内输液量≥[10 ml/kg/hr*1 h + 1 ml/kg/hr*71 h] ml(包括急诊室输注)。
- 液体分组阈值:>80%生理盐水为生理盐水组,>80%林格液为林格液组。
研究设计与关键结果
- 研究类型:回顾性队列研究,利用日本全国住院患者数据库。
- 样本量:共纳入8710例急性胰腺炎患者,其中生理盐水组657例(7.5%),林格液组8053例(92.5%)。
- 倾向性评分匹配后形成578对平衡队列。
- 主要终点:生理盐水组院内死亡率显著高于林格液组(12.8% [474/578] vs 8.5% [49/578];风险差4.3%;95%CI 0.3%至8.3%)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于ICU或HDU收治并接受充分液体复苏的急性胰腺炎患者,林格液可能优于生理盐水作为首选输注治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Fluid resuscitation is fundamental in acute pancreatitis (AP) treatment. However, the optimal choice between normal saline (NS) and Ringer's solution (RS), and its impact on mortality in critically ill patients, remains controversial. This retrospective cohort study, utilizing a national Japanese inpatient database, investigates this question.
METHODS: Using the Japanese Diagnosis Procedure Combination database between July 2010 and March 2021, we identified adult patients hospitalized in intensive care units (ICU) or high-dependency care units (HDU) for AP who survived at least three days and received sufficient fluid resuscitation (≥ [10 ml/kg/hr*1 h + 1 ml/kg/hr*71 h] ml) within three days of admission including emergency room infusions. Patients were classified into groups based on the predominant fluid type received: the NS group (> 80% normal saline) and the RS group (> 80% Ringer's solution). Propensity score matching was employed to reduce potential confounding factors and facilitate a balanced comparison of in-hospital mortality between the two groups.
RESULTS: Our analysis included 8710 patients with AP. Of these, 657 (7.5%) received predominantly NS, and 8053 (92.5%) received predominantly RS. Propensity score matching yielded 578 well-balanced pairs for comparison. The NS group demonstrated significantly higher in-hospital mortality than the RS group (12.8% [474/578] vs. 8.5% [49/578]; risk difference, 4.3%; 95% confidence interval, 0.3% to 8.3%).
CONCLUSIONS: In patients admitted to ICU or HDU with AP receiving adequate fluid resuscitation, RS can be a preferred infusion treatment compared to NS.
参考来源
- Horibe M, Kayashima A, Ohbe H, et al. Normal saline versus Ringer's solution and critical-illness mortality in acute pancreatitis: a nationwide inpatient database study. J Intensive Care. 2024. PMID: 39004762. doi:10.1186/s40560-024-00738-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。